UBS Group’s Dillards DDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-20,000
Closed -$5.37M 10413
2022
Q1
$5.37M Sell
20,000
-3,400
-15% -$878K ﹤0.01% 2471
2021
Q4
$5.73M Buy
+23,400
New +$6.16M ﹤0.01% 2678
2018
Q2
Sell
-120,000
Closed -$9.64M 8025
2018
Q1
$9.64M Buy
120,000
+90,000
+300% +$6.5M ﹤0.01% 1718
2017
Q4
$1.8M Buy
+30,000
New +$1.66M ﹤0.01% 3276
2017
Q1
Sell
-10,000
Closed -$627K 7697
2016
Q4
$627K Buy
+10,000
New +$657K ﹤0.01% 3941
2015
Q1
Sell
-502,000
Closed -$62.8M 8911
2014
Q4
$62.8M Buy
+502,000
New +$55.9M 0.04% 443

Other funds holding DDS

UBS Group's DDS Position: Q1 2026 in Review

UBS Group increased its Dillards (DDS) stake by 146% in Q1 2026, buying an estimated $61.6M and bringing the position to 166,707 shares worth $95.4M. The position accounts for 0.01% of the portfolio, ranked #1093.

UBS Group first reported a position in DDS in Q4 2014 and has held it in 46 quarters since. 316 funds tracked by Wall St. Rank hold DDS as of Q1 2026.

  • UBS Group held 166,707 shares of Dillards worth $95.4M as of Q1 2026.
  • UBS Group bought 98,812 Dillards shares in Q1 2026, an estimated $61.6M.
  • Dillards made up 0.01% of UBS Group's portfolio in Q1 2026, its #1093 holding.
  • UBS Group first reported a position in Dillards in Q4 2014 and has held it in 46 quarters since.
  • 316 funds tracked by Wall St. Rank held Dillards as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.